Newsfeed
Home /-
GRIN Therapeutics Announces the Initiation of the Beeline Trial for Radiprodil in Europe
GRIN Europe is very excited to share with you this press release in which Neurvati Neurosciences/GRIN Therapeutics, Inc. announces the initiation of its pivotal Phase 3 Beeline study in Europe, further advancing its global clinical program evaluating investigational radiprodil for GRIN-related neurodevelopmental disorder (GRIN-NDD). Building on the very encouraging clinical results of the Honeycomb Trial,…
-
GRIN Europe´s mission to foster family support, clinical care and research engagement in rare, GRIN-related disorders
On the occasion of Rare Disease Day, the GRIN Europe patients association is highlighting the emotional, societal and clinical implications of living with a rare GRIN disease and calls for cross-disease and interdisciplinary collaborations across national borders and medical specialties.
-
Beeline Study: Radiprodil for Children with GRIN-Related Neurodevelopmental Disorder
The Beeline Study is a global Phase 3 clinical trial testing radiprodil, an investigational medicine for children with GRIN-related neurodevelopmental disorder (GRIN-NDD) caused by gain-of-function changes in specific GRIN genes. Radiprodil works by targeting the GluN2B part of the NMDA receptor, which can be overactive in these genetic conditions. This study is for children from 1 month to 18 years old who have confirmed gain-of-function variants in GRIN1,…
-
The first patient has been dosed with radprodil in the Beeline trial!
We are delighted to share with you all that Neurvati Neurosciences/GRIN Therapeutics, Inc. issued a press release today announcing that the first patient has been dosed in its global Phase 3 Beeline clinical trial of investigational radiprodil in GRIN-related neurodevelopmental disorder (GRIN-NDD). You can find the press release here: https://lnkd.in/dvpctCTp We also share a heartfelt…
-
Dr. Natalia Juliá of the San Joan de Déu Hospital presents the results of the L-serine at the the EPNS Congress in Prague
Dr. Natalia Juliá, a member of the Neurometabolic team at the Sant Joan de Deu Hospital in Barcelona, Spain will speak at the European Paediatric Neurology Society (EPNS) Congress in Prague. She will do a podium presentation of the results of the L-Serine Clinical Trial: “Tolerability and efficacy of L-Serine in patients with GRIN-related encephalopathy”, on June…
-
Epilepsy in Autism – online webinar June 2, 2023
Empowering Voices: A Community-Directed Panel Discussion on Epilepsy in Autism Jun 2, 2023 02:30 PMT (22:30 GM) – FREE Online Event As an organization committed to serving individuals with autism, we at The Brain Foundation understand the unique challenges and uncertainties that come with a diagnosis of epilepsy. This online panel discussion aims to bridge…